.png "back to home page")
Oh there is. He is stock in the parent company that makes the drug the FDA approved yesterday as a treatment for #covid https://t.co/KoRho5Ryqa
— Barbara Malmet (@B52Malmet) October 23, 2020
Read an open letter from our Chief Medical Officer about today's @US_FDA approval of our antiviral treatment for COVID-19. https://t.co/JAyK3zJGD7
— Gilead Sciences (@GileadSciences) October 22, 2020
Can't believe this news. Biggest mockery of science, ethics and justice. Brazen ignorance of @WHO
— Dr Dhananjay Bakhle (@BakhleD) October 23, 2020
Data from #SolidarityTrial. Unequal treatment to #HydroxyChloroquine
where even EUA revoked. World needs explanation.https://t.co/1cE6UkKIj8
Dr Reddy's, Cipla, Cadila, Jubilant Life from listed space....hetero and mylan in unlisted
— Darshan Mehta (@darshanvmehta1) October 23, 2020
Remdesivir: Coronavirus treatment from Gilead approved by FDA https://t.co/NxZJmdLGj8
Remdesivir: Coronavirus treatment from Gilead approved by FDA
— Masayoshi Nakamura (@masayang) October 22, 2020
おお、レムデシビルがFDAから正式承認。
トランプは仮病だったとか言ってる人達はGileadの人達にすごく失礼な事をしているという自覚は...ないんだろうな。 https://t.co/fTVR4UaTr7
NEW: FDA approves #remdesivir as a treatment for #covid19. It had received emergency use authorization in May which allowed doctors to give it to hospitalised patients.
— Julianna Tatelbaum (@CNBCJulianna) October 22, 2020
This comes despite WHO's Solidarity Trial finding the drug had 'little or no effect.'https://t.co/Mz4Z4ucCrl
BIG NEWS:
— Sriram (@SriramMadras) October 22, 2020
Remdesivir: Coronavirus treatment from Gilead approved by FDA https://t.co/xkovalkEGZ
GileadのレムデシビルがFDAに正式承認され、アメリカ初の承認コロナ治療薬に。今までは緊急利用のみ承認されていたが、今後は入院レベルで適応となる。レムデシビルは静脈注射だが、Gileadは吸入用も開発中とのこと。肝臓に影響がある薬のため、錠剤の開発はないそう。https://t.co/CkqK6w8YXy
— 今村咲 (@saki_imamura) October 22, 2020
Today, under @realDonaldTrump’s leadership, @US_FDA has approved the first treatment for the Chinese virus.https://t.co/wAg5Neocxx
— Marsha Blackburn (@VoteMarsha) October 23, 2020
Today, the first antiviral drug for the treatment of #COVID19 patients was approved by @US_FDA. Years of investment from biopharmaceutical companies, countless setbacks and endless researcher perseverance brought us to this moment. https://t.co/vkTfX34uWN
— Stephen J. Ubl (@steveubl) October 22, 2020